Listed

Clorox Co: Form 10-Q for the period ended Mar 31, 2020

Filed with the SEC on May 1, 2020 and accepted by EDGAR at May 1, 2020, 16:16 ET.

Share

Management's discussion and analysis

As filed, 46,912 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(Dollars in millions, except share and per share data)

Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is designed to provide a reader of The Clorox Company’s (the Company or Clorox) financial statements with a narrative from the perspective of management on the Company’s financial condition, results of operations, liquidity and certain other factors that may affect future results. The following discussion of the Company’s financial condition and results of operations should be read in conjunction with MD&A and the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019, which was filed with the Securities and Exchange Commission (SEC) on August 14, 2019, and the unaudited condensed consolidated financial statements and related notes contained in this Quarterly Report on Form 10-Q (this Report). Unless otherwise noted, MD&A compares the three and nine month periods ended March 31, 2020 (the current period) to the three and nine month periods ended March 31, 2019 (the prior period), with percentage and basis point calculations based on rounded numbers, except for per share data and the effective tax rate.

EXECUTIVE OVERVIEW

Clorox is a leading multinational manufacturer and marketer of consumer and professional products with approximately 8,800 employees worldwide. Clorox sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, drug, pet and military stores, third-party and owned e-commerce channels, and distributors. Clorox markets some of the most trusted and recognized consumer brand names, including its namesake bleach and cleaning products, Pine-Sol® cleaners, Liquid-Plumr® clog removers, Poett® home care products, Fresh Step® cat litter, Glad® bags, wraps and containers, Kingsford® grilling products, Hidden Valley® dressings and sauces, Brita® water-filtration products, Burt’s Bees® natural personal care products, RenewLife® digestive health products, and Rainbow Light®, Natural Vitality™ and NeoCell® dietary supplements. The Company also markets industry-leading products and technologies for professional customers, including those sold under the CloroxPro™ and the Clorox Healthcare® brand names. The Company has operations in more than 25 countries or territories and sells its products in more than 100 markets.

The Company primarily markets its leading brands in midsized categories considered to be financially attractive. Most of the Company’s products compete with other nationally advertised brands within each category and with “private label” brands.

The Company operates through strategic business units (SBUs) that are aggregated into the following four reportable segments based on the economics and nature of the products sold. During the second quarter of fiscal year 2020, the Company’s Charcoal SBU within the Household reportable segment was renamed the Grilling SBU to reflect a broader strategic view of the category. There has been no change to the composition of the Grilling SBU or the Household reportable segment; therefore, no prior periods were restated.

  • Cleaning consists of Laundry, Home Care and Professional Products marketed and sold in the United States. Products within this segment include laundry additives, such as bleach products under the Clorox® brand and Clorox 2® stain fighter and color booster; home care products, primarily under the Clorox®, Formula 409®, Liquid-Plumr®, Pine-Sol®, S.O.S® and Tilex® brands; naturally derived products under the Green Works® brand; and professional cleaning, disinfecting and food service products under the CloroxPro™, Dispatch®, Clorox Healthcare®, Hidden Valley® and KC Masterpiece® brands.
  • Household consists of Grilling products, Bags and Wraps, Cat Litter, and Digestive Health products marketed and sold in the United States. Products within this segment include grilling products under the Kingsford® and Match Light® brands; bags, wraps and containers under the Glad® brand; cat litter products under the Fresh Step®, Scoop Away® and Ever Clean® brands; and digestive health products under the RenewLife® brand.
  • Lifestyle consists of Food products, Water Filtration systems and filters, Natural Personal Care products, and Dietary Supplements marketed and sold mainly in the United States. Products within this segment include dressings and sauces, primarily under the Hidden Valley®, KC Masterpiece®, Kingsford® and Soy Vay® brands; water-filtration systems and filters under the Brita® brand; natural personal care products under the Burt’s Bees® brand; and dietary supplements under the Rainbow Light®, Natural Vitality™ and NeoCell® brands.
  • International consists of products sold outside the United States. Products within this segment include laundry; home care; water filtration systems and filters; digestive health products; grilling products; cat litter products; food products; bags, wraps and containers; natural personal care products; and professional cleaning and disinfecting products primarily under the Clorox®, Glad®, PinoLuz®, Ayudin®, Limpido®, Clorinda®, Poett®, Mistolin®, Lestoil®, Bon Bril®, Brita®, Green Works®, Pine-Sol®, Agua Jane®, Chux®, RenewLife®, Kingsford®, Fresh Step®, Scoop Away®, Ever Clean®, KC Masterpiece®, Hidden Valley®, Burt’s Bees®, CloroxPro™, and Clorox Healthcare® brands.

RECENT EVENTS RELATED TO COVID-19

The novel coronavirus (COVID-19) pandemic has caused a severe global health crisis, along with economic and societal disruptions and uncertainties. As a result, we have taken an active role in addressing the ongoing pandemic’s impact on our employees, operations, customers, and consumers, including taking precautionary measures, such as implementing contingency plans, and making operational adjustments where necessary. The impact of COVID-19 and responses of governments, consumers, and others to the pandemic are affecting our business in many ways; however, we believe that the actions we are taking will help us emerge from this global pandemic operationally sound, and well positioned for continued long-term growth.

Commitment to Support People and Public Health

Our top priorities, from the beginning of this pandemic, have been the health and safety of our employees, our consumers, workers at healthcare facilities, and our communities. For example, we have taken extra precautions at our offices and manufacturing and distribution facilities, consistent with guidance from global, federal and local health authorities, such as social distancing, thermal scanning and partitions in our facilities. We have also implemented global travel restrictions and work-from-home policies for those employees who have the ability to work remotely. In addition, we have enhanced pay for our production employees, provided greater flexibility around sick-pay and work hours and established an employee emergency relief fund to provide COVID-19 related support to our employees. Furthermore, we and our foundations have made cash and product donations to various organizations to help front-line workers and communities respond to COVID-19.

Increasing our Capacity to Provide Needed Products and Changes in Costs

We have significantly increased our manufacturing production capacity for disinfecting cleaning products that are needed during this global health crisis and expect to continue to expand our production capacity for such products over the balance of the calendar year. We have done this, in part, by prioritizing the production of certain high-volume disinfecting cleaning products through significant reduction in the number of different types and sizes of disinfecting cleaning products we currently produce, by increasing production at our third party contract manufacturers and by reducing production employee changeover while managing social distancing. While we have experienced temporary closures of certain facilities, we have not experienced a material impact from a plant closure to date, and all of our plants and the vast majority of our contract manufacturers and suppliers continue to operate.

To date, we have had no material disruption in our access to necessary raw materials and other supplies or with our distribution network; however, we have experienced higher costs in certain areas as a result of COVID-19, such as transportation, logistics and production employee compensation, as well as incremental costs associated with newly added health screenings and enhanced cleaning and sanitation protocols to protect our employees at our facilities. In the future, we may decide to implement additional precautionary measures or operational adjustments as we deem prudent to meet consumer demand or help further ensure employee safety.

Other COVID-19 Items

For our fiscal third quarter ended March 31, 2020, we experienced increased demand for many of our products, especially our disinfecting cleaning products, in response to COVID-19, and expect strong demand for such products will continue throughout the rest of this fiscal year. Nevertheless, the extent of COVID-19’s effect on our operational and financial performance for the remainder of fiscal year 2020 and beyond will depend on future developments, including the duration, spread and intensity of the pandemic, our continued ability to manufacture and distribute our products, as well as any future government actions affecting consumers and the economy generally, all of which are uncertain and difficult to predict considering the rapidly evolving landscape.

COVID-19 has also impacted financial markets, and as such, in March 2020, we took certain actions to provide the Company with additional liquidity and flexibility, as described in the “Financial Position and Liquidity” section below. We will continue to actively monitor the potential impacts of COVID-19 on the commercial paper, credit and capital markets.

For further discussion of the possible impacts of the COVID-19 pandemic on our business, financial conditions and results of operations, see “Risk Factors” in Part II, Item 1A of this Report.

RESULTS OF OPERATIONS

CONSOLIDATED RESULTS

Three Months Ended 3/31/2020 3/31/2019 % Change Nine Months Ended 3/31/2020 3/31/2019 % Change
Net sales $1,783 $1,551 15% $4,738 $4,587 3%
Three Months Ended March 31, 2020 Percentage change versus the year-ago period Reported (GAAP) Net Sales Growth / (Decrease) Reported Volume Acquisitions & Divestitures Foreign Exchange Impact Price/Mix/Other (1) Organic Sales Growth / (Decrease) (Non-GAAP) (2) Organic Volume (3)
Cleaning 32% 34% —% —% (2)% 32% 34%
Household 2 5 — — (3) 2 5
Lifestyle 10 7 — — 3 10 7
International 11 16 — (11) 6 22 16
Total 15% 18% —% (2)% (1)% 17% 18%
Nine Months Ended March 31, 2020
Percentage change versus the year-ago period
Reported (GAAP) Net Sales Growth / (Decrease) Reported Volume Acquisitions & Divestitures Foreign Exchange Impact Price/Mix/Other (1) Organic Sales Growth / (Decrease) (Non-GAAP) (2) Organic Volume (3)
Cleaning 10% 12% —% —% (2)% 10% 12%
Household (6) (2) — — (4) (6) (2)
Lifestyle 6 5 — — 1 6 5
International 3 6 — (9) 6 12 6
Total 3% 6% —% (2)% (1)% 5% 6%

(1) This represents the net impact on net sales growth / (decrease) from pricing actions, mix and other factors.

(2) Organic sales growth / (decrease) is defined as net sales growth / (decrease) excluding the effect of any acquisitions and divestitures as well as changes in foreign exchange rates. See “Non-GAAP Financial Measures” below for reconciliation of organic sales growth / (decrease) to net sales growth, the most directly comparable GAAP financial measure.

(3) Organic volume represents volume excluding the effect of any acquisitions and divestitures.

Net sales in the current quarter increased by 15%, reflecting higher shipments across all reportable segments driven by increased demand due to the COVID-19 pandemic. Volume increased by 18% and outpaced net sales growth due to the impact of unfavorable foreign currency exchange rates and unfavorable price mix.

Net sales in the current nine month period increased by 3%, reflecting higher shipments in the Cleaning, Lifestyle and International reportable segments, partially offset by lower shipments in the Household reportable segment. Volume increased by 6% and outpaced net sales growth due to the impact of unfavorable foreign currency exchange rates and unfavorable price mix.

Three Months Ended 3/31/2020 3/31/2019 % Change Nine Months Ended 3/31/2020 3/31/2019 % Change
Gross profit $832 $673 24% $2,134 $1,994 7%
Gross margin 46.7% 43.4% 45.0% 43.5%

Gross margin, defined as gross profit as a percentage of net sales, increased by 330 basis points in the current period from 43.4% to 46.7%. The increase was primarily driven by higher volume and cost savings, partially offset by higher trade promotion spending.

Gross margin increased by 150 basis points in the current nine month period from 43.5% to 45.0%. The increase was primarily driven by cost savings, higher volume and the benefit of price increases implemented to offset inflation occurring in specific international markets, partially offset by higher trade promotion spending and manufacturing and logistics costs.

Three Months Ended 3/31/2020 3/31/2019 % Change % of Net Sales 3/31/2020 3/31/2019
Selling and administrative expenses $269 $216 25% 15.1% 13.9%
Advertising costs 184 161 14 10.3 10.4
Research and development costs 39 34 15 2.2 2.2
Nine Months Ended
% of Net Sales
3/31/2020 3/31/2019 % Change 3/31/2020 3/31/2019
Selling and administrative expenses $690 $639 8% 14.6% 13.9%
Advertising costs 461 445 4 9.7 9.7
Research and development costs 103 98 5 2.2 2.1

Selling and administrative expenses, as a percentage of net sales, increased by 120 basis points and 70 basis points in the current three and nine month periods, respectively. The increase in selling and administrative expenses was primarily due to higher incentive compensation expenses in both the current three and nine month periods, consistent with the Company’s performance-based compensation philosophy.

Advertising costs, as a percentage of net sales, remained essentially flat in the current three and nine month periods. The dollar increase in advertising expenses reflected the Company’s continued support behind its brands. The Company’s U.S. retail advertising spend as a percentage of net sales was approximately 12% and 11% in the current and year-ago quarters, respectively.

Research and development costs, as a percentage of net sales, remained essentially flat in the current three and nine month periods. The Company continues to focus on product innovation and cost savings.

Interest expense, Other (income) expense, net, and the effective tax rate on earnings

Three Months Ended 3/31/2020 3/31/2019 Nine Months Ended 3/31/2020 3/31/2019
Interest expense $24 $24 $74 $72
Other (income) expense, net 19 (2) 16 8
Effective tax rate on earnings 18.9% 21.8% 20.4% 20.8%

Other (income) expense, net was $19 and $(2) in the current and prior three month periods, respectively, and $16 and $8 in the current and prior nine month periods, respectively. The variances were primarily due to the impact from the revaluation of the Company's trust assets related to its non-qualified deferred compensation plans (see Note 4 of the Notes to Condensed Consolidated Financial Statements).

The effective tax rate on earnings was 18.9% and 20.4% for the current three and nine month periods, respectively, and 21.8% and 20.8% for the prior three and nine month periods, respectively. The decrease in the effective tax rate on earnings for the current three month period was primarily due to higher excess tax benefits, partially offset by a lower benefit from the release of uncertain tax positions. The decrease for the current nine month period was primarily due to a higher benefit from the release of uncertain tax positions, partially offset by lower excess tax benefits.

Diluted net earnings per share

Three Months Ended 3/31/2020 3/31/2019 % Change Nine Months Ended 3/31/2020 3/31/2019 % Change
Diluted net earnings per share $1.89 $1.44 31% $4.94 $4.45 11%

Diluted net earnings per share (EPS) increased by $0.45, or 31%, in the current three month period, primarily due to net sales growth and gross margin expansion, partially offset by higher selling and administrative expenses and higher advertising investments.

Diluted net earnings per share increased by $0.49, or 11%, in the current nine month period, primarily due to gross margin expansion, partially offset by higher selling and administrative expenses.

SEGMENT RESULTS

The following presents the results of operations from the Company’s reportable segments and certain unallocated costs reflected in Corporate (see Notes to Condensed Consolidated Financial Statements for a reconciliation of segment results to consolidated results):

Cleaning

Three Months Ended 3/31/2020 3/31/2019 % Change Nine Months Ended 3/31/2020 3/31/2019 % Change
Net sales $671 $508 32% $1,734 $1,579 10%
Earnings before income taxes 231 135 71 556 450 24

Volume, sales and earnings before income taxes increased by 34%, 32% and 71%, respectively, in the current three month period. The volume increase was driven by higher shipments in all strategic business units, mainly due to increased demand in response to the COVID-19 pandemic. The higher shipments in Home Care and Laundry were primarily driven by elevated demand for Clorox® disinfecting wipes, sprays and Clorox® disinfecting bleach. The higher shipments of Professional Products reflect growth across all categories. Volume growth outpaced net sales growth, primarily due to unfavorable mix and higher trade promotion spending. The increase in earnings before income taxes was primarily due to net sales growth, partially offset by higher advertising investments.

Volume, net sales and earnings before income taxes increased by 12%, 10% and 24%, respectively, in the current nine month period. The volume increase was driven by higher shipments in all strategic business units, mainly due to increased demands as a result of the COVID-19 pandemic. The higher shipments in Home Care were primarily driven by strength in Clorox® disinfecting wipes and sprays. The higher shipments of Professional Products reflect growth across all categories. Volume growth outpaced net sales growth, mainly due to unfavorable mix. The increase in earnings before income taxes was primarily due to net sales growth, cost savings and favorable commodity costs, partially offset by higher advertising investments.

Household

Three Months Ended 3/31/2020 3/31/2019 % Change Nine Months Ended 3/31/2020 3/31/2019 % Change
Net sales $500 $489 2% $1,241 $1,324 (6)%
Earnings before income taxes 107 93 15 169 198 (15)

Volume, net sales and earnings before income taxes increased by 5%, 2% and 15%, respectively, in the current three month period. The volume increase was driven by higher shipments in Cat Litter and Grilling due to increased consumer demand, partially offset by lower shipments of RenewLife® Digestive Health products. Volume growth outpaced net sales growth primarily due to higher trade promotion spending and unfavorable mix, partially offset by the benefit of price increases in Grilling implemented in the back half of fiscal year 2019. The increase in earnings before income taxes was mainly due to net sales growth and cost savings.

Volume, net sales and earnings before income taxes decreased by 2%, 6% and 15%, respectively, in the current nine month period. The volume decrease was mainly driven by lower shipments in Glad® Bags and Wraps, mainly due to previous distribution losses, lower shipments of RenewLife® Digestive Health products due to continued category and competitive headwinds and lower shipments in Grilling. These increases were partially offset by higher shipments in Cat Litter due to increased consumer demand. The variance between volume and net sales was primarily due to higher trade promotion spending. The decrease in earnings before income taxes was mainly due to lower net sales, partially offset by cost savings.

Lifestyle

Three Months Ended 3/31/2020 3/31/2019 % Change Nine Months Ended 3/31/2020 3/31/2019 % Change
Net sales $339 $309 10% $1,008 $953 6%
Earnings before income taxes 66 51 29 221 191 16

Volume, net sales and earnings before income taxes increased by 7%, 10% and 29%, respectively, in the current three month period. Both volume growth and net sales growth were primarily driven by higher shipments of Brita® Water Filtration and Food products due to increased demand in light of the COVID-19 pandemic, partially offset by lower shipments in the Nutranext Dietary Supplements business due to a supply disruption related to the COVID-19 pandemic. Net sales growth outpaced volume growth, mainly due to favorable mix. The increase in earnings before income taxes was primarily due to net sales growth, partially offset by higher advertising investments.

Volume, net sales and earnings before income taxes increased by 5%, 6% and 16%, respectively, in the current nine month period. Both volume growth and net sales growth were driven by higher shipments of Brita® Water Filtration, Food, and Burt’s Bees® Natural Personal Care products, partially offset by lower shipments in the Nutranext Dietary Supplements business. Higher shipments of Brita® Water Filtration and Food products were mainly driven by increased demand in light of the COVID-19 pandemic. Higher shipments of Burt’s Bees® Natural Personal Care products were mainly driven by continued strength in lip and face care. The increase in earnings before income taxes was primarily due to net sales growth.

International

Three Months Ended 3/31/2020 3/31/2019 % Change Nine Months Ended 3/31/2020 3/31/2019 % Change
Net sales $273 $245 11% $755 $731 3%
Earnings before income taxes 36 24 50 106 77 38

Volume, net sales and earnings before income taxes increased by 16%, 11% and 50% respectively, in the current three month period. Volume increased primarily driven by higher shipments in Latin America and Canada. Volume growth outpaced net sales growth mainly due to the impact of unfavorable foreign currency exchange rates, partially offset by the benefit of price increases implemented to offset inflation. The increase in earnings before income taxes was primarily due to the net sales growth, partially offset by the impact of unfavorable foreign currency exchange rates, mainly in Argentina.

Volume, net sales and earnings before income taxes increased by 6%, 3% and 38% respectively, in the current nine month period. Volume increased primarily driven by higher shipments in Canada, Latin America and Australia. Volume growth outpaced net sales growth, mainly due to the impact of unfavorable foreign currency exchange rates, partially offset by the benefit of price increases implemented to offset inflation. The increase in earnings before income taxes was largely due to net sales growth, partially offset by the impact of unfavorable foreign currency exchange rates, mainly in Argentina.

Argentina

The business environment in Argentina continues to be challenging due to significant volatility in Argentina’s currency, high inflation, economic recession and additional uncertainty related to the impacts of COVID-19. The Company operates in Argentina through certain wholly owned subsidiaries (collectively, “Clorox Argentina”). Clorox Argentina manufactures products at two plants that it owns and operates across Argentina and markets those products to consumers throughout the country. Products are advertised nationally and sold to consumers through wholesalers and retail outlets located throughout Argentina. Sales are made primarily through the use of Clorox Argentina’s sales force. Small amounts of products produced in Argentina are exported each year, including sales to the Company’s other subsidiaries located primarily in Latin America. Clorox Argentina obtains its raw materials almost entirely from local sources; however, the price of some of these raw materials may fluctuate with changes in the value of the U.S. dollar against the Argentine peso. The Company also conducts research and development activities at its owned facility in Buenos Aires, Argentina. Additionally, Clorox Argentina performs marketing, legal, and various other shared service activities to support the Company’s International operations. Clorox Argentina, in turn, benefits from shared service activities performed within other geographic locations, such as information technology support and manufacturing technical assistance.

Effective July 1, 2018, under the requirements of U.S. GAAP, Argentina was designated as a highly inflationary economy, since it has experienced cumulative inflation of approximately 100 percent or more over a three year period. As a result, beginning July 1, 2018, the U.S. dollar replaced the Argentine peso as the functional currency of the Company’s subsidiaries in Argentina. Consequently, gains and losses from non-U.S. dollar denominated monetary assets and liabilities of Clorox Argentina are recognized in Other (income) expense, net in the condensed consolidated statement of earnings.

As of September 2019, the government of Argentina reinstated foreign exchange controls in response to further declines in the value of the Argentine peso, limiting the Company’s ability to convert Argentine pesos to U.S. dollars and transfer U.S. dollars outside of Argentina. As of March 31, 2020 and June 30, 2019, the net asset position, excluding goodwill, of Clorox Argentina was $44 and $47, respectively. Of these net assets, cash balances were approximately $13 and $16 as of March 31, 2020 and June 30, 2019, respectively. Net sales from Clorox Argentina represented approximately 2% of the Company’s consolidated net sales for both the nine months ended March 31, 2020 and the fiscal year ended June 30, 2019.

Volatility in the exchange rate is expected to continue in the future, which, along with competition, changes in the retail, labor and macro-economic environment, and implemented and future additional legal limitations instituted to restrict foreign exchange transactions, as well as government price controls, could have an adverse impact on Clorox Argentina’s liquidity, net sales, net earnings, cash flows and net monetary asset position. The Company is closely monitoring developments in Argentina and continues to take steps intended to mitigate the adverse conditions, but there can be no assurances that these actions will be able to mitigate these conditions as they may occur.

Corporate

Certain non-allocated administrative costs, interest income, interest expense, and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, prepaid expenses and other current assets, property and equipment, other investments, and deferred taxes.

Three Months Ended 3/31/2020 3/31/2019 % Change Nine Months Ended 3/31/2020 3/31/2019 % Change
Losses before income taxes $(143) $(63) 127% $(262) $(184) 42%

Losses before income taxes increased by $80 in the current three month period due to higher employee and incentive compensation expenses and COVID-19 related expenditures.

Losses before income taxes increased by $78 in the current nine month period due to higher employee and incentive compensation expenses and COVID-19 related expenditures.

FINANCIAL POSITION AND LIQUIDITY

The Company’s financial condition and liquidity remained strong as of March 31, 2020. The following table summarizes cash activities:

Nine Months Ended 3/31/2020 3/31/2019
Net cash provided by operations $806 $603
Net cash used for investing activities (145) (126)
Net cash used for financing activities (261) (429)

Operating Activities

Net cash provided by operations was $806 in the current nine month period, compared with $603 in the prior nine month period. The year-over-year increase was primarily due to decreases in working capital (higher receivables offset by lower inventories due primarily to an increase in quarter-end sales in the current year, and higher payables in the current year due to the timing of vendor payments), higher cash earnings and prior fiscal year’s voluntary increase in the Company’s contributions to the domestic retirement income plans.

Investing Activities

Net cash used for investing activities was $145 in the current nine month period, compared with $126 in the prior nine month period. The year-over-year increase was mainly due to higher capital spending in the current nine-month period, primarily driven by the acquisition of a manufacturing facility.

Financing Activities

Net cash used for financing activities was $261 in the current nine month period, compared with $429 in the prior nine month period. The year-over-year decrease was mainly due to an increase in cash sourced from short-term borrowings and lower treasury stock purchases, partially offset by increased cash dividend payments.

Capital Resources and Liquidity

Global financial markets have experienced a significant increase in volatility due to heightened uncertainty over the adverse economic impact caused by the COVID-19 outbreak. Notwithstanding these potential adverse market conditions, the Company believes it will have the funds necessary to support our short-term liquidity and operating needs based on our anticipated ability to generate positive cash flows from operations in the future, access to capital markets enabled by our strong short-term and long-term credit ratings, and current borrowing availability under the credit agreement.

Credit Arrangements

On November 15, 2019, the Company entered into a new $1,200 revolving credit agreement (the Credit Agreement) that matures in November 2024. The Credit Agreement replaced a prior $1,100 revolving credit agreement (the Prior Agreement) in place since February 2017. No termination fees or penalties were incurred in connection with entering the new Credit Agreement, which was considered a debt modification.

There was $450 outstanding under the Credit Agreement as of March 31, 2020, and no borrowings under the Prior Agreement as of June 30, 2019. The Company borrowed under the Credit Agreement primarily to pay down maturing commercial paper balances in light of current uncertainty in short-term credit markets resulting from the COVID-19 outbreak.

The Credit Agreement includes certain restrictive covenants and limitations. The primary restrictive covenant is a minimum ratio of 4.0 calculated as total earnings before interest, taxes, depreciation and amortization and non-cash asset impairment charges (Consolidated EBITDA) to total interest expense for the trailing four quarters (Interest Coverage ratio), as defined and described in the Credit Agreement.

The following table sets forth the calculation of the Interest Coverage ratio as of March 31, 2020, using Consolidated EBITDA for the trailing four quarters, as contractually defined in the Credit Agreement:

Twelve Months Ended 3/31/2020
Earnings from operations $870
Add back:
Interest expense 99
Income tax expense 212
Depreciation and amortization 180
Non-cash asset impairment charges 1
Deduct:
Interest income (2)
Consolidated EBITDA $1,360
Interest expense $99
Interest Coverage ratio 13.7

The Company was in compliance with all restrictive covenants and limitations in the Credit Agreement as of March 31, 2020, and anticipates being in compliance with all restrictive covenants for the foreseeable future. The Company continues to monitor the financial markets and assess its ability to continue to draw on its credit agreement, and currently expects it will continue to have access to borrowings under the Credit Agreement.

As of March 31, 2020, the Company maintained $38 of foreign and other credit lines, of which $2 was outstanding.

Stock Repurchases and Dividend Payments

As of March 31, 2020, the Company had two stock repurchase programs: an open-market purchase program with an authorized aggregate purchase amount of up to $2,000, which has no expiration date, and a program to offset the anticipated impact of dilution related to stock-based awards (the Evergreen Program), which has no authorization limit on the dollar amount and no expiration date.

Stock repurchases under the two stock repurchase programs were as follows for the periods indicated:

Three Months Ended 3/31/2020 Amount Shares (in thousands) 3/31/2019 Amount Shares (in thousands) Nine Months Ended 3/31/2020 Amount Shares (in thousands) 3/31/2019 Amount Shares (in thousands)
Open-market purchase program $— — $— — $85 577 $78 591
Evergreen Program 30 184 73 466 134 847 231 1,551
Total stock repurchases $30 184 $73 466 $219 1,424 $309 2,142

Dividends per share declared and total dividends paid were as follows for the periods indicated:

Three Months Ended 3/31/2020 3/31/2019 Nine Months Ended 3/31/2020 3/31/2019
Dividends per share declared $1.06 $0.96 $3.18 $2.88
Total dividends paid 133 123 399 368

31

CONTINGENCIES

See Notes to Condensed Consolidated Financial Statements for information on the Company’s contingencies.

RECENTLY ISSUED ACCOUNTING STANDARDS

See Notes to Condensed Consolidated Financial Statements for a summary of recently issued accounting standards relevant to the Company.

NON-GAAP FINANCIAL MEASURES

The non-GAAP financial measures that may be included in this MD&A and the reasons management believes they are useful to investors are described below. These measures should be considered supplemental in nature and are not intended to be a substitute for the related financial information prepared in accordance with U.S. GAAP. In addition, these measures may not be the same as similarly named measures presented by other companies.

The Company uses the term Consolidated EBITDA because it is a term used in its revolving credit agreement. As defined in the Credit Agreement, Consolidated EBITDA represents earnings before interest, taxes, depreciation and amortization and non-cash asset impairment charges. Interest Coverage ratio is the ratio of Consolidated EBITDA to interest expense. The Company’s management believes disclosure of Consolidated EBITDA provides useful information to investors because it is used in the primary restrictive covenant in the Credit Agreement. For additional discussion of the Interest Coverage ratio and a reconciliation of Consolidated EBITDA, see “Financial Position and Liquidity - Financing Activities - Credit Arrangements” above.

Organic sales growth / (decrease) is defined as net sales growth excluding the effect of foreign exchange rate changes and any acquisitions and divestitures. Management believes that the presentation of organic sales growth / (decrease) is useful to investors because it excludes sales from any acquisitions and divestitures, which results in a comparison of sales only from the businesses that the Company was operating throughout the relevant periods, and the impact of foreign exchange rate changes, which are out of the control of the Company and management.

The following table provides a reconciliation of organic sales growth / (decrease) (non-GAAP) to net sales growth / (decrease) (GAAP), the most comparable GAAP measure:

Three Months Ended March 31, 2020 Percentage change versus the year-ago period Cleaning Household Lifestyle International Total
Net sales growth / (decrease) (GAAP) 32% 2% 10% 11% 15%
Add: Foreign Exchange — — — 11% 2%
Add/(Subtract): Divestitures/Acquisitions — — — — —
Organic sales growth / (decrease) (non-GAAP) 32% 2% 10% 22% 17%
Nine Months Ended March 31, 2020
Percentage change versus the year-ago period
Cleaning Household Lifestyle International Total
Net sales growth / (decrease) (GAAP) 10% (6)% 6% 3% 3%
Add: Foreign Exchange — — — 9% 2%
Add/(Subtract): Divestitures/Acquisitions — — — — —
Organic sales growth / (decrease) (non-GAAP) 10% (6)% 6% 12% 5%

32

Cautionary Statement

This Quarterly Report on Form 10-Q (this Report), including the exhibits hereto and the information incorporated by reference herein, contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, statements related to the expected or potential impact of the novel coronavirus (COVID-19) pandemic, and the related responses of governments, consumers, customers, suppliers, employees and the Company, on our business, operations, employees, financial condition and results of operations, and any such forward-looking statements, whether concerning the COVID-19 pandemic or otherwise, involve risks, assumptions and uncertainties. Except for historical information, statements about future volumes, sales, organic sales growth, foreign currencies, costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, foreign currency exchange rates, tax rates, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management’s estimates, beliefs, assumptions and projections. Words such as “could,” “may,” “expects,” “anticipates,” “targets,” “goals,” “projects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “will,” “predicts,” and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management’s expectations, or could affect the Company’s ability to achieve its strategic goals, are described in the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019 and in this Report, as updated from time to time in the Company’s Securities and Exchange Commission filings. These factors include, but are not limited to, the uncertainties relating to the impact of COVID-19 on the Company’s business, operations, employees, financial condition and results of operations as well as:

  • intense competition in the Company’s markets;
  • the impact of the changing retail environment, including the growth of alternative retail channels and business models, and changing consumer preferences;
  • volatility and increases in commodity costs such as resin, sodium hypochlorite and agricultural commodities, and increases in energy, transportation or other costs;
  • the ability of the Company to drive sales growth, increase prices and market share, grow its product categories and manage favorable product and geographic mix;
  • dependence on key customers and risks related to customer consolidation and ordering patterns;
  • risks related to the Company’s use of and reliance on information technology systems, including potential security breaches, cyber-attacks, privacy breaches or data breaches that result in the unauthorized disclosure of consumer, customer, employee or Company information, or service interruptions;
  • the Company’s ability to maintain its business reputation and the reputation of its brands and products;
  • the impact of COVID-19 on the availability of, and efficiency of the supply, manufacturing and distribution systems for, the Company’s products, including any disruption to such systems;
  • long-term changes in consumer preference or demand for our products as a result of any shortages or lack of availability of any products in the near-term;
  • risks relating to acquisitions, new ventures and divestitures, and associated costs, including the potential for asset impairment charges related to, among others, intangible assets and goodwill; and the ability to complete announced transactions and, if completed, integration costs and potential contingent liabilities related to those transactions;
  • lower revenue, increased costs or reputational harm resulting from government actions and regulations;
  • the ability of the Company to successfully manage global political, legal, tax and regulatory risks, including changes in regulatory or administrative activity;
  • uncertain worldwide, regional and local economic and financial market conditions, including as a result of fear of exposure to or actual impacts of a widespread disease outbreak, such as COVID-19;
  • risks related to international operations and international trade, including foreign currency fluctuations, such as devaluations, and foreign currency exchange rate controls, including periodic changes in such controls; changes in U.S. immigration or trade policies, including the imposition of new or additional tariffs; labor claims and labor unrest; inflationary pressures, particularly in Argentina; political instability and the uncertainty regarding the outcome of Brexit; government-imposed price controls or other regulations; potential negative impact and liabilities from the use, storage and transportation of chlorine in certain international markets where chlorine is used in the production of bleach; widespread health emergencies, such as COVID-19; and the possibility of nationalization, expropriation of assets or other government action;
  • the ability of the Company to innovate and to develop and introduce commercially successful products, or expand into adjacent categories and countries;
  • the impact of product liability claims, labor claims and other legal or tax proceedings, including in foreign jurisdictions;
  • the ability of the Company to implement and generate cost savings and efficiencies;
  • the success of the Company’s business strategies;
  • risks related to additional increases in the estimated fair value of P&G’s interest in the Glad® business;
  • the Company’s ability to attract and retain key personnel;
  • supply disruptions, including as a result of COVID-19 and governments’ responses thereto, and other risks inherent in reliance on a limited base of suppliers;
  • environmental matters, including costs associated with the remediation and monitoring of past contamination, and possible increases in costs resulting from actions by relevant regulators, and the handling and/or transportation of hazardous substances;
  • increased focus by governmental and non-governmental organizations, customers, consumers and investors on sustainability issues, including those related to climate change;
  • the facilities of the Company and its suppliers being subject to disruption by events beyond the Company’s control, including work stoppages, cyber-attacks, natural disasters, disease outbreaks or pandemics, such as COVID-19, and terrorism;
  • the Company’s ability to maximize, assert and defend its intellectual property rights;
  • any infringement or claimed infringement by the Company of third-party intellectual property rights;
  • the accuracy of the Company’s estimates and assumptions on which its financial projections are based;
  • the effect of the Company’s indebtedness and credit rating on its business operations and financial results;
  • the Company’s ability to access capital markets and other funding sources, as well as continued or increased market volatility;
  • the Company’s ability to pay and declare dividends or repurchase its stock in the future;
  • uncertainties relating to tax positions, tax disputes and changes in the Company’s tax rate, and any additional effects of the Tax Act on the Company;
  • the Company’s ability to maintain an effective system of internal controls;
  • the impacts of potential stockholder activism; and
  • risks related to the Company’s discontinuation of operations in Venezuela.

The Company’s forward-looking statements in this Report are based on management’s current views, beliefs, assumptions and expectations regarding future events and speak only as of the date of this Report. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.

In this Report, unless the context requires otherwise, the terms “the Company,” “Clorox,” “we,” “us,” and “our” refer to The Clorox Company and its subsidiaries.

Market risk

As filed, 325 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have not been any material changes to the Company’s market risk since June 30, 2019. For additional information, refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in Exhibit 99.1 of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019.

Controls and procedures

As filed, 1,162 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this Report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures, as of the end of the period covered by this Report, were effective such that the information required to be disclosed by the Company in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

No change in the Company’s internal control over financial reporting occurred during the third fiscal quarter of the fiscal year ending June 30, 2020, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-01-01 to 2020-03-31$1.78bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2019-07-01 to 2020-03-31$4.74bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2020-01-01 to 2020-03-31$951.0mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2019-07-01 to 2020-03-31$2.60bnus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2020-01-01 to 2020-03-31$832.0mus-gaap:GrossProfit
Gross profit9 months2019-07-01 to 2020-03-31$2.13bnus-gaap:GrossProfit
Research and development3 months2020-01-01 to 2020-03-31$39.0mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2019-07-01 to 2020-03-31$103.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2020-01-01 to 2020-03-31$269.0mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2019-07-01 to 2020-03-31$690.0mus-gaap:SellingGeneralAndAdministrativeExpense
Interest expense3 months2020-01-01 to 2020-03-31$24.0mus-gaap:InterestExpense
Interest expense9 months2019-07-01 to 2020-03-31$74.0mus-gaap:InterestExpense
Income tax3 months2020-01-01 to 2020-03-31$56.0mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2019-07-01 to 2020-03-31$161.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-01-01 to 2020-03-31$241.0mus-gaap:NetIncomeLoss
Net income9 months2019-07-01 to 2020-03-31$629.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-01-01 to 2020-03-31$1.89us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2019-07-01 to 2020-03-31$4.94us-gaap:EarningsPerShareDiluted
Basic EPS3 months2020-01-01 to 2020-03-31$1.92us-gaap:EarningsPerShareBasic
Basic EPS9 months2019-07-01 to 2020-03-31$5.01us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2020-01-01 to 2020-03-31127,328,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2019-07-01 to 2020-03-31127,236,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2019-07-01 to 2020-03-31$806.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2019-07-01 to 2020-03-31$158.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases9 months2019-07-01 to 2020-03-31$225.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2020-03-31$496.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-03-31$1.75bnus-gaap:AssetsCurrent
Total assetsAt period end2020-03-31$5.85bnus-gaap:Assets
Current liabilitiesAt period end2020-03-31$1.79bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-03-31$5.16bnus-gaap:Liabilities
Long-term debtAt period end2020-03-31$2.29bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2020-03-31$638.0mus-gaap:DebtCurrent
Short-term borrowingsAt period end2020-03-31$188.0mus-gaap:CommercialPaper
Shareholders' equityAt period end2020-03-31$695.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000021076-20-000008. Last ingested by Listed: Nov 10, 2026, 22:57 ET. Listed shows no prices and gives no investment advice.